June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Claudin 5 expression has distinct impacts on the Immune profiles of mouse models of AMD
Author Affiliations & Notes
  • Kieva Byrne
    Smurfit Institute of Genetics, The University of Dublin Trinity College, Dublin, Ireland
  • Natalie Hudson
    Smurfit Institute of Genetics, The University of Dublin Trinity College, Dublin, Ireland
  • Conor Delaney
    Smurfit Institute of Genetics, The University of Dublin Trinity College, Dublin, Ireland
  • Avril Reddy
    Smurfit Institute of Genetics, The University of Dublin Trinity College, Dublin, Ireland
  • Matthew Campbell
    Smurfit Institute of Genetics, The University of Dublin Trinity College, Dublin, Ireland
  • Footnotes
    Commercial Relationships   Kieva Byrne, None; Natalie Hudson, None; Conor Delaney, None; Avril Reddy, None; Matthew Campbell, None
  • Footnotes
    Support  Trinity College Dublin Ussher Award
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 2700. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Kieva Byrne, Natalie Hudson, Conor Delaney, Avril Reddy, Matthew Campbell; Claudin 5 expression has distinct impacts on the Immune profiles of mouse models of AMD. Invest. Ophthalmol. Vis. Sci. 2021;62(8):2700.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The role of claudin-5 as a key mediator of the inner Blood Retinal Barrier (iBRB) and Blood Brain Barrier (BBB) are well established. However, the role of this Tight Junction (TJ) protein in diseases affecting retinal homeostasis, remains poorly understood. In this study we analyse the effects of Claudin-5 expression disruption on Age-Related Macular Degeneration (AMD) pathology through the analysis of the immune profiles of two novel mouse models of the disease.

Methods : The first model analysed is created through a Cldn5 flox Tie2cre system in which endothelial Cldn5 expression is heterozygosity is established. RNA samples were isolated from the retinas of these mice for qPCR analysis. Cre negative animals were used as controls.

The second model under investigation utilised AAV vectors expressing an shRNA targeting claudin-5 to decrease Cldn5 expression levels in the retinal endothelium. These mice were fed a high cholesterol diet (HCD) to further induce AMD pathogenesis. RNA samples were isolated from the RPE of these mice and subjected to a PCR array of 35 genes representing various inflammatory markers, markers of endoplasmic reticulum (ER) stress, and oxidative stress markers. Controls used were mice administered with non-targeting shRNA.

Results : Analysis of Cldn5 tie2-cre+ retinas show a significant decrease in expression of TJ genes, Marveld2 and Lsr concomitant to Cldn5 suppression, (*p=0.048, *p=0.0493, respectively). Numerous inflammatory markers also show downregulation including Il-1β (*p=0.0455) and macrophage markers such as Tmem119 (**p=0.0089).
Results from the RPE qPCR panel show that inflammatory markers are significantly upregulated in Cldn5 deficient mice. Such markers included cytokines such as Cxcl10 (**p=0.0038), components of the complement system, Traf6, (*p=0.0197) and Toll like receptor 2 (Tlr2, **p=0.0039).

Conclusions : The immune profile of these two disease models show trends towards two distinct inflammatory outcomes. This disparity in inflammatory phenotypes may be attributed to the synergistic effect of a HCD with decreased claudin 5 expression, resulting in the differential recruitment and activation of immune cells within the retina. Therefore, these results provide an interesting insight into the immunological implications of the disruption of claudin-5 expression in such disease contexts.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×